Zobrazeno 1 - 10
of 17
pro vyhledávání: '"M S, Dal"'
Autor:
M. S. Dal, B. Uncu Ulu, A. Uzay, O. M. Akay, S. Besisik, M. N. Yenerel, S. Celik, L. Kaynar, O. K. Yucel, B. Deveci, M. Sonmez, O. Mehtap, H. S. Bekoz, C. Sunu, O. Salim, T. Ulas, S. Karti, F. Altuntas, B. Ferhanoglu, T. Firatli Tuglular
Publikováno v:
HemaSphere, Vol 6, Pp 1113-1114 (2022)
Externí odkaz:
https://doaj.org/article/b284239d76754e4cb345accd80f8e68b
Autor:
A. Basturk, M. Bagci, M. S. Dal, T. Hacibekiroglu, S. Kabukcu Hacioglu, I. Aydogdu, M. Kizil Cakar, C. Sunu, G. Akgun Cagliyan, A. Kaya, M. H. Dogu, S. Celik, H. Uskudar Teke, M. A. Erkurt, O. Ekinci, B. Turgut, A. Tekinalp, S. Korkmaz, T. Ulas, F. Altuntas
Publikováno v:
HemaSphere, Vol 6, Pp 1943-1944 (2022)
Externí odkaz:
https://doaj.org/article/bb5ad81aefa042eaa5e36919fc6a9b4f
Autor:
S, Seçilmiş, D, İskender, B A, Candır, E, Bozan, S, Yaman, B U, Ulu, T N, Yiğenoğlu, M K, Çakar, M S, Dal, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 26(10)
Heavy menstrual bleeding (HMB) is the most common cause of iron deficiency anemia (IDA) in premenopausal women. Clinical studies have shown that iron carboxymaltose (ICM) is an appropriate, effective, and well-tolerated treatment option for clinical
Autor:
J, Yildiz, M, Bagci, S, Sayin, A, Kaya, F, Yilmaz, O, Ekinci, M S, Dal, A, Basturk, I, Aydogdu, M, Albayrak, A, Dogan, M A, Erkurt, S, Korkmaz, T, Ulas, B, Eser, F, Altuntas
Publikováno v:
European review for medical and pharmacological sciences. 26(4)
In this study, we aimed to investigate the clinicopathological features and survival of CD, which is quite rare and has many unknowns.This study was conducted by retrospectively evaluating patients diagnosed with CD in six different centers in Turkey
Autor:
D, İskender, M, İbanoğlu, S, Seçilmiş, N A, Baysal, M K, Çakar, M S, Dal, B U, Ulu, S Y, Ergani, A, Kaymak, T T, İlhan, S, Başçı, T N, Yiğenoğlu, C, İskender, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 26(3)
This study was conducted to retrospectively investigate the pregnancy outcomes of patients who underwent stem cell transplantation (SCT). We also aimed at determining the reasons for avoiding pregnancy despite prolonged remission.The study population
Autor:
D, İskender, M K, Çakar, M S, Dal, N A, Baysal, A, Merdin, M, Bakırtas, B U, Ulu, S, Başcı, T N, Yiğenoğlu, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 26(3)
The aim of the present study was to compare the effects of nivolumab bridge to allogeneic hematopoietic stem cell transplantation (allo-SCT) on progression-free survival (PFS) and overall survival (OS) and toxicity profile.The study population consis
Autor:
J, Yildiz, B U, Ulu, T N, Yiğenoğlu, S, Başçı, T, Darçın, M, Bakırtaş, D, Şahin, H, Batgi, A, Merdin, N A, Baysal, D, İskender, M K, Çakar, M S, Dal, F, Altuntaş
Publikováno v:
European review for medical and pharmacological sciences. 25(10)
Although the clinical features and treatment results of Hodgkin lymphoma (HL) in young adults are well known, it is thought that the disease may have different characteristics in elderly patients with HL, which constitutes almost 25% of the group. In
Autor:
H Mohamed, M Moussa, R Ibrahim, G Soryal, M Negm, A El Hosainy, T N Yigenoglu, B Uncu Ulu, S Bascı, M Bakırtas, T Darcın, D Sahin, D Iskender, M Kizil Cakar, M S Dal, F Altuntas, Hematology, Abdurrahman, Yurtaslan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c490c7eba0fbf93b244af057d9ffd22
Publikováno v:
Nigerian Journal of Clinical Practice; Vol 21, No 6 (2018); 711-715
Aim: This study aimed to evaluate the clinical and pathological features of ocular adnexal lymphoma (OAL) and the treatment results in an eye care service center in Turkey.Materials and Methods: The data sets of the patients diagnosed with OAL acquir
Publikováno v:
European review for medical and pharmacological sciences. 19(22)
The purpose of this study was to evaluate the uric acid (UA) and C-reactive protein (CRP) levels in patients with immune thrombocytopenic purpura (ITP).Forty patients with newly diagnosed ITP and 40 healthy individuals were enrolled in the study. The